Skip to Main Content

Paper Details

Lipoprotein(a) lowering and cardiovascular risk reduction by PCSK9 inhibitors.
Atherosclerosis
2
2022
Author NameAffiliation
Maya S SafarovaUniversity of Kansas Hospital and Medical Center
Iftikhar J KulloMayo Clinic
  • 1 - 2

Datasets

Release 1.2